349 related articles for article (PubMed ID: 31933261)
1. D-ribose and pathogenesis of Alzheimer's disease.
Javed M; Ahmad MI; Javed H; Naseem S
Mol Biol Rep; 2020 Mar; 47(3):2289-2299. PubMed ID: 31933261
[TBL] [Abstract][Full Text] [Related]
2. Advanced Glycation End Products Modulate Amyloidogenic APP Processing and Tau Phosphorylation: A Mechanistic Link between Glycation and the Development of Alzheimer's Disease.
Batkulwar K; Godbole R; Banarjee R; Kassaar O; Williams RJ; Kulkarni MJ
ACS Chem Neurosci; 2018 May; 9(5):988-1000. PubMed ID: 29384651
[TBL] [Abstract][Full Text] [Related]
3. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.
Prasad K
Mol Cell Biochem; 2019 Sep; 459(1-2):95-112. PubMed ID: 31079281
[TBL] [Abstract][Full Text] [Related]
4. Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.
Gasparotto J; Girardi CS; Somensi N; Ribeiro CT; Moreira JCF; Michels M; Sonai B; Rocha M; Steckert AV; Barichello T; Quevedo J; Dal-Pizzol F; Gelain DP
J Biol Chem; 2018 Jan; 293(1):226-244. PubMed ID: 29127203
[TBL] [Abstract][Full Text] [Related]
5. Receptor for Advanced Glycation End Products: Dementia and Cognitive Impairment.
Singh A; Ansari VA; Mahmood T; Ahsan F; Wasim R; Shariq M; Parveen S; Maheshwari S
Drug Res (Stuttg); 2023 Jun; 73(5):247-250. PubMed ID: 36889338
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.
Takeuchi M; Yamagishi S
Curr Pharm Des; 2008; 14(10):973-8. PubMed ID: 18473848
[TBL] [Abstract][Full Text] [Related]
7. Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model.
Guo C; Zhang S; Li JY; Ding C; Yang ZH; Chai R; Wang X; Wang ZY
Sci Rep; 2016 Jul; 6():29396. PubMed ID: 27406855
[TBL] [Abstract][Full Text] [Related]
8. AGEs RAGE Pathways: Alzheimer's Disease.
Maheshwari S
Drug Res (Stuttg); 2023 Jun; 73(5):251-254. PubMed ID: 36940723
[TBL] [Abstract][Full Text] [Related]
9. RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity.
Fang F; Yu Q; Arancio O; Chen D; Gore SS; Yan SS; Yan SF
Hum Mol Genet; 2018 Mar; 27(6):1002-1014. PubMed ID: 29329433
[TBL] [Abstract][Full Text] [Related]
10. Glycation exacerbates the neuronal toxicity of β-amyloid.
Li XH; Du LL; Cheng XS; Jiang X; Zhang Y; Lv BL; Liu R; Wang JZ; Zhou XW
Cell Death Dis; 2013 Jun; 4(6):e673. PubMed ID: 23764854
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.
Sasaki N; Toki S; Chowei H; Saito T; Nakano N; Hayashi Y; Takeuchi M; Makita Z
Brain Res; 2001 Jan; 888(2):256-262. PubMed ID: 11150482
[TBL] [Abstract][Full Text] [Related]
12. Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer's Disease.
Aaseth J; Skalny AV; Roos PM; Alexander J; Aschner M; Tinkov AA
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502369
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
14. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
Lue LF; Yan SD; Stern DM; Walker DG
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):249-66. PubMed ID: 15975028
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
[TBL] [Abstract][Full Text] [Related]
16. Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions.
Koerich S; Parreira GM; de Almeida DL; Vieira RP; de Oliveira ACP
Curr Neuropharmacol; 2023; 21(2):219-234. PubMed ID: 36154605
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease.
Leclerc E; Sturchler E; Vetter SW; Heizmann CW
Rev Neurosci; 2009; 20(2):95-110. PubMed ID: 19774788
[TBL] [Abstract][Full Text] [Related]
18. The role of the Maillard reaction in other pathologies: Alzheimer's disease.
Colaco CA; Ledesma MD; Harrington CR; Avila J
Nephrol Dial Transplant; 1996; 11 Suppl 5():7-12. PubMed ID: 9044299
[TBL] [Abstract][Full Text] [Related]
19. Toxic advanced glycation end products (TAGE) theory in Alzheimer's disease.
Sato T; Shimogaito N; Wu X; Kikuchi S; Yamagishi S; Takeuchi M
Am J Alzheimers Dis Other Demen; 2006; 21(3):197-208. PubMed ID: 16869341
[TBL] [Abstract][Full Text] [Related]
20. The novel RAGE interactor PRAK is associated with autophagy signaling in Alzheimer's disease pathogenesis.
Kim Y; Kim C; Son SM; Song H; Hong HS; Han SH; Mook-Jung I
Mol Neurodegener; 2016 Jan; 11():4. PubMed ID: 26758977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
